Clinical Trials Research Market Analysis

The global clinical trials market is segmented and analyzed for demand and supply by application into cardiology, oncology, dermatology, ophthalmology, and autoimmune diseases. Amongst these segments, the cardiology segment is estimated to acquire the largest share by the end of 2031. The growth of the segment can be attributed to the rising prevalence of cardiovascular diseases among the global population. For instance, in 2019, almost 18 million people died due to some sort of cardiovascular disease globally summing up to around 30% of the entire population.

Our in-depth analysis of the global clinical trials market includes the following segments: